ESR1 and breast carcinoma: Highly differentiated breast tumors show increased expression of ERs and estrogen synthesis driving liganded ER activation and genome stabilization.In moderately differentiated breast cancers, the loss of hormone receptors upregulates the expression of HER2 receptors and kinase cascade members, strengthening the unliganded activation of scarcely occurring ERs.